Table II.
Preoperative and Postoperative Mean Transaortic Pressure Gradients in ViV-TAVI Bioprosthetic Valve Fracture
Patient | Baseline mean gradient, mm Hg | After TAVI, mm Hg | After bioprosthetic valve fracture, mm Hg | 1-mo follow-up, mm Hg | 12-mo follow-up, mm Hg |
---|---|---|---|---|---|
1 | 43 | 12 | 9 | 25 | 23 |
2 | 42 | 7 | 5 | 10 | 6 |
3 | 40 | 8 | 8 | 19 | 20 |
4 | 12 | 21 | 15 | 9 | 11 |
5 | 45 | 10 | 7 | 22 | 25 |
6 | 46 | 7 | 7 | 10 | 11 |
7 | 30 | 15 | 14 | 13 | 14 |
8 | 49 | 15 | 9 | 14 | 15 |
9 | 44 | 12 | 13 | 17 | 19 |
10 | 67 | 15 | 10 | 14 | 13 |
11 | 33 | 12 | 7 | 11 | 13 |
12 | 47 | 28 | 10 | 9 | N/A |
13 | 54 | 17 | 3 | 16 | 17 |
14 | 51 | 15 | 7 | 8 | 7 |
15 | 19 | 12 | 9 | 11 | 12 |
16 | 37 | 18 | 11 | 9 | 9 |
17 | 27 | 10 | 7 | 10 | 8 |
18a | 40 | 18 | 8 | 14 | 8 |
19 | 37 | 10 | 6 | 9 | 10 |
20 | 41 | 28 | 12 | 14 | 10 |
21a | 50 | 23 | 11 | 17 | 14 |
22 | 60 | 20 | 11 | 13 | 7 |
23 | 48 | 29 | 8 | 9 | 11 |
24 | 41 | 13 | 8 | 14 | 12 |
25a | 32 | N/A | 4 | 13 | 4 |
N/A, not applicable; TAVR, transcatheter aortic valve implantation.
SI conversion factor: To convert mm Hg to kPa, multiply by 0.133.
Post-TAVI gradients were not obtained for patients 18, 21, and 25 because the TAVI valve could not fully expand secondary to restriction by the bioprosthetic valve. Bioprosthetic valve fracturing was therefore promptly pursued.